Global Gamma Knife Market size was valued at USD 234.28 Mn. in 2024, and the total Global Gamma Knife Market revenue is expected to grow by 3.7% from 2025 to 2032, reaching nearly USD 313.3 Mn.Gamma Knife Market Overview:
The gamma knife is a type of sophisticated radiation therapy that is used to treat cancer in both adults and children. A gamma knife is a beam of highly focused gamma rays that are used to accurately cut or eliminate tumors or damaged cells, usually in the brain, while less perpetration and no damage to the normal cells in that particular region. Medium brain tumors, trigeminal neuralgia, epilepsy, nerve problems that cause chronic pain, aberrant blood vessel formations called arteriovenous malformations, and other neurological conditions are treated with gamma knife technology.To know about the Research Methodology :- Request Free Sample Report
Gamma Knife Market Dynamics:
The rising prevalence of cancer, brain tumors, and neurological illnesses, as well as the increasing usage of gamma knife tools in surgical facilities as a result of the growing inclination for less invasive surgeries, are expected to drive the market. Furthermore, the market is likely to be driven by technology improvements and upgrades. The global incidence of neurological illnesses such as brain tumors and epilepsy is rapidly increasing. According to data released by the American Brain Tumor Association (ABTA) in 2017, about 7,00,000 persons in the United States have a brain tumor, with nearly 80,000 new primary brain tumor cases reported each year. Nonmalignant and malignant tumors are the two most common forms. In 2018, cancer was the second leading cause of mortality worldwide, accounting for nearly 9.0 million fatalities. Cancer incidence is anticipated to climb by 70% in the next two decades, according to WHO predictions. There are also certain constraints in the market, such as fierce competition among existing companies, high procedure costs, limited equipment availability, and a lack of awareness about gamma knife therapy among the rural population in developing and undeveloped nations. Some of the most well-known companies are focused on new technologies in order to supply advanced medical care. Elekta, a pioneer in precision radiation therapy provider, recently unveiled the Leksell Gamma Knife Lightning, a cutting-edge innovation for intracranial stereotactic radiosurgery. This invention is perfectly in line with Elekta's development strategy, which focuses on helping the healthcare industry by improving operational efficiency, reducing drafting time, and allowing clinicians to focus more on patient-centric care.Gamma Knife Market Segment Analysis:
Based on Disease Indication, the Malignant tumors segment is anticipated to adhere to the growth of the Gamma Knife Market. Malignant tumors accounted for the highest revenue share of 36.4% in 2024. For primary malignant brain tumors, gamma knife therapy is utilized as an additional treatment. Traditional surgical treatment options are frequently chosen over fractionated external beam radiation therapy. Furthermore, over the projection period, the increased occurrence of primary brain tumors is expected to enhance demand. Additionally, gamma knife therapy's related benefits over other treatment options, such as enhanced accuracy, precision, and treatment safety, are expected to drive up demand in surgical centers. It does not require an incision, unlike other invasive surgical procedures, and this is expected to boost demand. Based on System Type, the Gamma Knife market is segmented into Gamma Knife Icon, Perfexion, and Others. Among these, Gamma Knife Icon dominated the Gamma Knife Market in 2024, due to its advanced features like real-time cone-beam CT imaging, frameless treatment options, and the ability to treat multiple lesions in one session. These advantages enhance precision, improve workflow efficiency, and increase patient comfort. As hospitals and specialty clinics prioritize technology and flexibility, the Icon system has become the preferred choice, steadily replacing older models and capturing the largest market share globally.Regional Segment:
The Asia Pacific dominated the total market with a revenue share of 41.6 % in 2023. The region's dominance is due to a high prevalence of brain tumors, increased awareness among healthcare professionals about non-invasive treatment options such as stereotactic procedures, high adoption of these devices in surgery facilities, and improved healthcare infrastructure. Japan had the greatest revenue share in this area in 2019. Japan ranked as the second-largest market in terms of volume. Increased disease load, increased cancer and brain tumor prevalence, and the growing use of gamma knife tools in surgery centers are all contributing to its domination. Furthermore, Asia Pacific is predicted to emerge as the fastest-growing region with a growth rate of 4.1 % throughout the projection period, owing to rapidly emerging economies, advances in healthcare facilities, and a growing senior population. The objective of the report is to present a comprehensive analysis of the Global Gamma Knife Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Gamma Knife Market dynamics, structure by analyzing the market segments and project the Global Gamma Knife Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Global Market make the report investor’s guide.Gamma Knife Market Scope: Inquire before buying
Gamma Knife Market Report Coverage Details Base Year: 2024 Forecast Period: 2025-2032 Historical Data: 2019 to 2024 Market Size in 2024: USD 234.28 Mn. Forecast Period 2025 to 2032 CAGR: 3.7% Market Size in 2032: USD 313.3 Mn. Segments Covered: by Disease Indication Malignant Tumors Benign Tumors Brain Metastases Arteriovenous Malformations (AVMs) Trigeminal Neuralgia Ocular Diseases by Patient Positioning Frame-Based Systems Frameless Systems by System Type Gamma Knife Icon Gamma Knife Perfexion Others by End-User Hospitals Specialty Clinics Ambulatory Surgical Centers Gamma Knife Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Gamma Knife Market, Key Players:
1. Elekta AB 2. Varian Medical Systems 3. Cyber Medical Corp. 4. ET Medical Group 5. GE Healthcare 6. Masep Infini Global Inc. Huiheng Medical, Inc 7. Nordion Inc., 8. American Shared Hospital Services 9. Austromar S.R.O. 10. Combimar & Agemar SpA 11. Shine International Transportation 12. Transglory S.A. 13. New Lines CO, Ltd 14. Pacific Star International. China 15. SHANGHAI SNWI MEDICAL CO., LTD. 16. Shenzhen Tengfei Yu Technology Co., Ltd. 17. Shanghai Even Medical Instruments Co., Ltd.FAQs:
1. What is the global Gamma Knife Market value in 2024? Ans: The global Gamma Knife Market value in 2024 was estimated as USD 234.28 Mn. 2. What is the global Gamma Knife Market growth? Ans: The global Gamma Knife Market is anticipated to grow with a CAGR of 3.7% in the forecast period and is likely to reach USD 313.3 Mn by the end of 2032. 3. Which Indication segment is expected to dominate the global Gamma Knife Market during the forecast period? Ans: The malignant tumors segment accounted for the maximum revenue share in 2024. Gamma knife therapy is exclusively used as adjunctive therapy for primary malignant brain tumors. 4. Which region is expected to dominate the global Gamma Knife Market during the forecast period? Ans: The Asia Pacific dominated the gamma knife market with a share of 3.7% in 2024. This is attributable to a high incidence of brain tumors, rising awareness amongst healthcare professionals regarding noninvasive treatment alternatives. 5. What is the key driving factor for the growth of the global Gamma Knife Market? Ans: Key factors that are driving the market growth include the rapid surge in the global incidence of neurological diseases such as brain tumors and epilepsy, rising adoption of the instruments in surgical centers, and product launch.
1. Gamma Knife Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Gamma Knife Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Key Players Benchmarking 2.3.1. Company Name 2.3.2. Business Segment 2.3.3. End-user Segment 2.3.4. Revenue (2024) 2.3.5. Company Locations 2.4. Leading Gamma Knife Market Companies, by market capitalization 2.5. Market Structure 2.5.1. Market Leaders 2.5.2. Market Followers 2.5.3. Emerging Players 2.6. Mergers and Acquisitions Details 3. Gamma Knife Market: Dynamics 3.1. Gamma Knife Market Trends by Region 3.1.1. North America Gamma Knife Market Trends 3.1.2. Europe Gamma Knife Market Trends 3.1.3. Asia Pacific Gamma Knife Market Trends 3.1.4. Middle East and Africa Gamma Knife Market Trends 3.1.5. South America Gamma Knife Market Trends 3.2. Gamma Knife Market Dynamics by Region 3.2.1. North America 3.2.1.1. North America Gamma Knife Market Drivers 3.2.1.2. North America Gamma Knife Market Restraints 3.2.1.3. North America Gamma Knife Market Opportunities 3.2.1.4. North America Gamma Knife Market Challenges 3.2.2. Europe 3.2.2.1. Europe Gamma Knife Market Drivers 3.2.2.2. Europe Gamma Knife Market Restraints 3.2.2.3. Europe Gamma Knife Market Opportunities 3.2.2.4. Europe Gamma Knife Market Challenges 3.2.3. Asia Pacific 3.2.3.1. Asia Pacific Gamma Knife Market Drivers 3.2.3.2. Asia Pacific Gamma Knife Market Restraints 3.2.3.3. Asia Pacific Gamma Knife Market Opportunities 3.2.3.4. Asia Pacific Gamma Knife Market Challenges 3.2.4. Middle East and Africa 3.2.4.1. Middle East and Africa Gamma Knife Market Drivers 3.2.4.2. Middle East and Africa Gamma Knife Market Restraints 3.2.4.3. Middle East and Africa Gamma Knife Market Opportunities 3.2.4.4. Middle East and Africa Gamma Knife Market Challenges 3.2.5. South America 3.2.5.1. South America Gamma Knife Market Drivers 3.2.5.2. South America Gamma Knife Market Restraints 3.2.5.3. South America Gamma Knife Market Opportunities 3.2.5.4. South America Gamma Knife Market Challenges 3.3. PORTER’s Five Forces Analysis 3.4. PESTLE Analysis 3.5. Technology Roadmap 3.6. Regulatory Landscape by Region 3.6.1. North America 3.6.2. Europe 3.6.3. Asia Pacific 3.6.4. Middle East and Africa 3.6.5. South America 3.7. Key Opinion Leader Analysis For Gamma Knife Industry 3.8. Analysis of Government Schemes and Initiatives For Gamma Knife Industry 3.9. Gamma Knife Market Trade Analysis 3.10. The Global Pandemic Impact on Gamma Knife Market 4. Gamma Knife Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2024-2032 4.1. Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 4.1.1. Malignant Tumors 4.1.2. Benign Tumors 4.1.3. Brain Metastases 4.1.4. Arteriovenous Malformations (AVMs) 4.1.5. Trigeminal Neuralgia 4.1.6. Ocular Diseases 4.2. Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 4.2.1. Frame-Based Systems 4.2.2. Frameless Systems 4.3. Gamma Knife Market Size and Forecast, by System Type (2024-2032) 4.3.1. Gamma Knife Icon 4.3.2. Gamma Knife Perfexion 4.3.3. Others 4.4. Gamma Knife Market Size and Forecast, by End-User (2024-2032) 4.4.1. Hospitals 4.4.2. Specialty Clinics 4.4.3. Ambulatory Surgical Centers 4.5. Gamma Knife Market Size and Forecast, by Region (2024-2032) 4.5.1. North America 4.5.2. Europe 4.5.3. Asia Pacific 4.5.4. Middle East and Africa 4.5.5. South America 5. North America Gamma Knife Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 5.1. North America Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 5.1.1. Malignant Tumors 5.1.2. Benign Tumors 5.1.3. Brain Metastases 5.1.4. Arteriovenous Malformations (AVMs) 5.1.5. Trigeminal Neuralgia 5.1.6. Ocular Diseases 5.2. North America Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 5.2.1. Frame-Based Systems 5.2.2. Frameless Systems 5.3. North America Gamma Knife Market Size and Forecast, by System Type (2024-2032) 5.3.1. Gamma Knife Icon 5.3.2. Gamma Knife Perfexion 5.3.3. Others 5.4. North America Gamma Knife Market Size and Forecast, by End-User (2024-2032) 5.4.1. Hospitals 5.4.2. Specialty Clinics 5.4.3. Ambulatory Surgical Centers 5.5. North America Gamma Knife Market Size and Forecast, by Country (2024-2032) 5.5.1. United States 5.5.1.1. United States Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 5.5.1.1.1. Malignant Tumors 5.5.1.1.2. Benign Tumors 5.5.1.1.3. Brain Metastases 5.5.1.1.4. Arteriovenous Malformations (AVMs) 5.5.1.1.5. Trigeminal Neuralgia 5.5.1.1.6. Ocular Diseases 5.5.1.2. United States Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 5.5.1.2.1. Frame-Based Systems 5.5.1.2.2. Frameless Systems 5.5.1.3. United States Gamma Knife Market Size and Forecast, by System Type (2024-2032) 5.5.1.3.1. Gamma Knife Icon 5.5.1.3.2. Gamma Knife Perfexion 5.5.1.3.3. Others 5.5.1.4. United States Gamma Knife Market Size and Forecast, by End-User (2024-2032) 5.5.1.4.1. Hospitals 5.5.1.4.2. Specialty Clinics 5.5.1.4.3. Ambulatory Surgical Centers 5.5.2. Canada 5.5.2.1. Canada Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 5.5.2.1.1. Malignant Tumors 5.5.2.1.2. Benign Tumors 5.5.2.1.3. Brain Metastases 5.5.2.1.4. Arteriovenous Malformations (AVMs) 5.5.2.1.5. Trigeminal Neuralgia 5.5.2.1.6. Ocular Diseases 5.5.2.2. Canada Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 5.5.2.2.1. Frame-Based Systems 5.5.2.2.2. Frameless Systems 5.5.2.3. Canada Gamma Knife Market Size and Forecast, by System Type (2024-2032) 5.5.2.3.1. Gamma Knife Icon 5.5.2.3.2. Gamma Knife Perfexion 5.5.2.3.3. Others 5.5.2.4. Canada Gamma Knife Market Size and Forecast, by End-User (2024-2032) 5.5.2.4.1. Hospitals 5.5.2.4.2. Specialty Clinics 5.5.2.4.3. Ambulatory Surgical Centers 5.5.3. Mexico 5.5.3.1. Mexico Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 5.5.3.1.1. Malignant Tumors 5.5.3.1.2. Benign Tumors 5.5.3.1.3. Brain Metastases 5.5.3.1.4. Arteriovenous Malformations (AVMs) 5.5.3.1.5. Trigeminal Neuralgia 5.5.3.1.6. Ocular Diseases 5.5.3.2. Mexico Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 5.5.3.2.1. Frame-Based Systems 5.5.3.2.2. Frameless Systems 5.5.3.3. Mexico Gamma Knife Market Size and Forecast, by System Type (2024-2032) 5.5.3.3.1. Gamma Knife Icon 5.5.3.3.2. Gamma Knife Perfexion 5.5.3.3.3. Others 5.5.3.4. Mexico Gamma Knife Market Size and Forecast, by End-User (2024-2032) 5.5.3.4.1. Hospitals 5.5.3.4.2. Specialty Clinics 5.5.3.4.3. Ambulatory Surgical Centers 6. Europe Gamma Knife Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 6.1. Europe Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 6.2. Europe Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 6.3. Europe Gamma Knife Market Size and Forecast, by System Type (2024-2032) 6.4. Europe Gamma Knife Market Size and Forecast, by End-User (2024-2032) 6.5. Europe Gamma Knife Market Size and Forecast, by Country (2024-2032) 6.5.1. United Kingdom 6.5.1.1. United Kingdom Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 6.5.1.2. United Kingdom Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 6.5.1.3. United Kingdom Gamma Knife Market Size and Forecast, by System Type (2024-2032) 6.5.1.4. United Kingdom Gamma Knife Market Size and Forecast, by End-User (2024-2032) 6.5.2. France 6.5.2.1. France Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 6.5.2.2. France Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 6.5.2.3. France Gamma Knife Market Size and Forecast, by System Type (2024-2032) 6.5.2.4. France Gamma Knife Market Size and Forecast, by End-User (2024-2032) 6.5.3. Germany 6.5.3.1. Germany Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 6.5.3.2. Germany Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 6.5.3.3. Germany Gamma Knife Market Size and Forecast, by System Type (2024-2032) 6.5.3.4. Germany Gamma Knife Market Size and Forecast, by End-User (2024-2032) 6.5.4. Italy 6.5.4.1. Italy Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 6.5.4.2. Italy Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 6.5.4.3. Italy Gamma Knife Market Size and Forecast, by System Type (2024-2032) 6.5.4.4. Italy Gamma Knife Market Size and Forecast, by End-User (2024-2032) 6.5.5. Spain 6.5.5.1. Spain Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 6.5.5.2. Spain Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 6.5.5.3. Spain Gamma Knife Market Size and Forecast, by System Type (2024-2032) 6.5.5.4. Spain Gamma Knife Market Size and Forecast, by End-User (2024-2032) 6.5.6. Sweden 6.5.6.1. Sweden Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 6.5.6.2. Sweden Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 6.5.6.3. Sweden Gamma Knife Market Size and Forecast, by System Type (2024-2032) 6.5.6.4. Sweden Gamma Knife Market Size and Forecast, by End-User (2024-2032) 6.5.7. Austria 6.5.7.1. Austria Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 6.5.7.2. Austria Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 6.5.7.3. Austria Gamma Knife Market Size and Forecast, by System Type (2024-2032) 6.5.7.4. Austria Gamma Knife Market Size and Forecast, by End-User (2024-2032) 6.5.8. Rest of Europe 6.5.8.1. Rest of Europe Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 6.5.8.2. Rest of Europe Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 6.5.8.3. Rest of Europe Gamma Knife Market Size and Forecast, by System Type (2024-2032) 6.5.8.4. Rest of Europe Gamma Knife Market Size and Forecast, by End-User (2024-2032) 7. Asia Pacific Gamma Knife Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 7.1. Asia Pacific Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 7.2. Asia Pacific Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 7.3. Asia Pacific Gamma Knife Market Size and Forecast, by System Type (2024-2032) 7.4. Asia Pacific Gamma Knife Market Size and Forecast, by End-User (2024-2032) 7.5. Asia Pacific Gamma Knife Market Size and Forecast, by Country (2024-2032) 7.5.1. China 7.5.1.1. China Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 7.5.1.2. China Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 7.5.1.3. China Gamma Knife Market Size and Forecast, by System Type (2024-2032) 7.5.1.4. China Gamma Knife Market Size and Forecast, by End-User (2024-2032) 7.5.2. S Korea 7.5.2.1. S Korea Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 7.5.2.2. S Korea Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 7.5.2.3. S Korea Gamma Knife Market Size and Forecast, by System Type (2024-2032) 7.5.2.4. S Korea Gamma Knife Market Size and Forecast, by End-User (2024-2032) 7.5.3. Japan 7.5.3.1. Japan Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 7.5.3.2. Japan Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 7.5.3.3. Japan Gamma Knife Market Size and Forecast, by System Type (2024-2032) 7.5.3.4. Japan Gamma Knife Market Size and Forecast, by End-User (2024-2032) 7.5.4. India 7.5.4.1. India Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 7.5.4.2. India Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 7.5.4.3. India Gamma Knife Market Size and Forecast, by System Type (2024-2032) 7.5.4.4. India Gamma Knife Market Size and Forecast, by End-User (2024-2032) 7.5.5. Australia 7.5.5.1. Australia Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 7.5.5.2. Australia Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 7.5.5.3. Australia Gamma Knife Market Size and Forecast, by System Type (2024-2032) 7.5.5.4. Australia Gamma Knife Market Size and Forecast, by End-User (2024-2032) 7.5.6. Indonesia 7.5.6.1. Indonesia Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 7.5.6.2. Indonesia Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 7.5.6.3. Indonesia Gamma Knife Market Size and Forecast, by System Type (2024-2032) 7.5.6.4. Indonesia Gamma Knife Market Size and Forecast, by End-User (2024-2032) 7.5.7. Malaysia 7.5.7.1. Malaysia Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 7.5.7.2. Malaysia Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 7.5.7.3. Malaysia Gamma Knife Market Size and Forecast, by System Type (2024-2032) 7.5.7.4. Malaysia Gamma Knife Market Size and Forecast, by End-User (2024-2032) 7.5.8. Vietnam 7.5.8.1. Vietnam Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 7.5.8.2. Vietnam Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 7.5.8.3. Vietnam Gamma Knife Market Size and Forecast, by System Type (2024-2032) 7.5.8.4. Vietnam Gamma Knife Market Size and Forecast, by End-User (2024-2032) 7.5.9. Taiwan 7.5.9.1. Taiwan Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 7.5.9.2. Taiwan Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 7.5.9.3. Taiwan Gamma Knife Market Size and Forecast, by System Type (2024-2032) 7.5.9.4. Taiwan Gamma Knife Market Size and Forecast, by End-User (2024-2032) 7.5.10. Rest of Asia Pacific 7.5.10.1. Rest of Asia Pacific Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 7.5.10.2. Rest of Asia Pacific Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 7.5.10.3. Rest of Asia Pacific Gamma Knife Market Size and Forecast, by System Type (2024-2032) 7.5.10.4. Rest of Asia Pacific Gamma Knife Market Size and Forecast, by End-User (2024-2032) 8. Middle East and Africa Gamma Knife Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 8.1. Middle East and Africa Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 8.2. Middle East and Africa Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 8.3. Middle East and Africa Gamma Knife Market Size and Forecast, by System Type (2024-2032) 8.4. Middle East and Africa Gamma Knife Market Size and Forecast, by End-User (2024-2032) 8.5. Middle East and Africa Gamma Knife Market Size and Forecast, by Country (2024-2032) 8.5.1. South Africa 8.5.1.1. South Africa Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 8.5.1.2. South Africa Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 8.5.1.3. South Africa Gamma Knife Market Size and Forecast, by System Type (2024-2032) 8.5.1.4. South Africa Gamma Knife Market Size and Forecast, by End-User (2024-2032) 8.5.2. GCC 8.5.2.1. GCC Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 8.5.2.2. GCC Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 8.5.2.3. GCC Gamma Knife Market Size and Forecast, by System Type (2024-2032) 8.5.2.4. GCC Gamma Knife Market Size and Forecast, by End-User (2024-2032) 8.5.3. Nigeria 8.5.3.1. Nigeria Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 8.5.3.2. Nigeria Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 8.5.3.3. Nigeria Gamma Knife Market Size and Forecast, by System Type (2024-2032) 8.5.3.4. Nigeria Gamma Knife Market Size and Forecast, by End-User (2024-2032) 8.5.4. Rest of ME&A 8.5.4.1. Rest of ME&A Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 8.5.4.2. Rest of ME&A Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 8.5.4.3. Rest of ME&A Gamma Knife Market Size and Forecast, by System Type (2024-2032) 8.5.4.4. Rest of ME&A Gamma Knife Market Size and Forecast, by End-User (2024-2032) 9. South America Gamma Knife Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 9.1. South America Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 9.2. South America Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 9.3. South America Gamma Knife Market Size and Forecast, by System Type(2024-2032) 9.4. South America Gamma Knife Market Size and Forecast, by End-User (2024-2032) 9.5. South America Gamma Knife Market Size and Forecast, by Country (2024-2032) 9.5.1. Brazil 9.5.1.1. Brazil Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 9.5.1.2. Brazil Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 9.5.1.3. Brazil Gamma Knife Market Size and Forecast, by System Type (2024-2032) 9.5.1.4. Brazil Gamma Knife Market Size and Forecast, by End-User (2024-2032) 9.5.2. Argentina 9.5.2.1. Argentina Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 9.5.2.2. Argentina Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 9.5.2.3. Argentina Gamma Knife Market Size and Forecast, by System Type (2024-2032) 9.5.2.4. Argentina Gamma Knife Market Size and Forecast, by End-User (2024-2032) 9.5.3. Rest Of South America 9.5.3.1. Rest Of South America Gamma Knife Market Size and Forecast, by Disease Indication (2024-2032) 9.5.3.2. Rest Of South America Gamma Knife Market Size and Forecast, by Patient Positioning (2024-2032) 9.5.3.3. Rest Of South America Gamma Knife Market Size and Forecast, by System Type (2024-2032) 9.5.3.4. Rest Of South America Gamma Knife Market Size and Forecast, by End-User (2024-2032) 10. Company Profile: Key Players 10.1. Elekta AB 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Varian Medical Systems 10.3. Cyber Medical Corp. 10.4. ET Medical Group 10.5. GE Healthcare 10.6. Masep Infini Global Inc. Huiheng Medical, Inc 10.7. Nordion Inc., 10.8. American Shared Hospital Services 10.9. Austromar S.R.O. 10.10. Combimar & Agemar SpA 10.11. Shine International Transportation 10.12. Transglory S.A. 10.13. New Lines CO, Ltd 10.14. Pacific Star International. China 10.15. SHANGHAI SNWI MEDICAL CO., LTD. 10.16. Shenzhen Tengfei Yu Technology Co., Ltd. 10.17. Shanghai Even Medical Instruments Co., Ltd. 11. Key Findings 12. Industry Recommendations 13. Gamma Knife Market: Research Methodology 14. Terms and Glossary
